The global Colorectal Cancer Therapeutics market was valued at US$ 12490 million in 2022 and is projected to reach US$ 17250 million by 2029, at a CAGR of 4.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Therapeutics. This report contains market size and forecasts of Colorectal Cancer Therapeutics in global, including the following market information:
Global Colorectal Cancer Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diagnostics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Therapeutics include Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron and Bayer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Colorectal Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Colorectal Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Global Colorectal Cancer Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Colorectal Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinic
- Research Institutions
Global Colorectal Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Colorectal Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Colorectal Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Colorectal Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Taiho Pharma
- Merck KGaA
- Amgen
- Takeda
- Roche
- Eli Lilly
- Sanofi
- Regeneron
- Bayer
- Onyx
- Bristol-Myers Squib
- Sumitomo Dainippon Pharma
- Array BioPharma
- Hutchison MediPharma
- Jiangsu Hengrui Medicine
- Jiangsu Chia-Tai Tianqing
- Suzhou Zelgen Biopharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Colorectal Cancer Therapeutics, market overview.
Chapter 2: Global Colorectal Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Colorectal Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colorectal Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Colorectal Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colorectal Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colorectal Cancer Therapeutics Overall Market Size
2.1 Global Colorectal Cancer Therapeutics Market Size: 2022 VS 2032
2.2 Global Colorectal Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Colorectal Cancer Therapeutics Players in Global Market
3.2 Top Global Colorectal Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Colorectal Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Colorectal Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Colorectal Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Colorectal Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Colorectal Cancer Therapeutics Market Size Markets, 2022 & 2032
4.1.2 Diagnostics
4.1.3 Therapeutics
4.2 By Type - Global Colorectal Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Colorectal Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Colorectal Cancer Therapeutics Revenue, 2024-2032
4.2.3 By Type - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colorectal Cancer Therapeutics Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Research Institutions
5.2 By Application - Global Colorectal Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Colorectal Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Colorectal Cancer Therapeutics Revenue, 2024-2032
5.2.3 By Application - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Colorectal Cancer Therapeutics Market Size, 2022 & 2032
6.2 By Region - Global Colorectal Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Colorectal Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Colorectal Cancer Therapeutics Revenue, 2024-2032
6.2.3 By Region - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Colorectal Cancer Therapeutics Revenue, 2018-2032
6.3.2 US Colorectal Cancer Therapeutics Market Size, 2018-2032
6.3.3 Canada Colorectal Cancer Therapeutics Market Size, 2018-2032
6.3.4 Mexico Colorectal Cancer Therapeutics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Colorectal Cancer Therapeutics Revenue, 2018-2032
6.4.2 Germany Colorectal Cancer Therapeutics Market Size, 2018-2032
6.4.3 France Colorectal Cancer Therapeutics Market Size, 2018-2032
6.4.4 U.K. Colorectal Cancer Therapeutics Market Size, 2018-2032
6.4.5 Italy Colorectal Cancer Therapeutics Market Size, 2018-2032
6.4.6 Russia Colorectal Cancer Therapeutics Market Size, 2018-2032
6.4.7 Nordic Countries Colorectal Cancer Therapeutics Market Size, 2018-2032
6.4.8 Benelux Colorectal Cancer Therapeutics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Colorectal Cancer Therapeutics Revenue, 2018-2032
6.5.2 China Colorectal Cancer Therapeutics Market Size, 2018-2032
6.5.3 Japan Colorectal Cancer Therapeutics Market Size, 2018-2032
6.5.4 South Korea Colorectal Cancer Therapeutics Market Size, 2018-2032
6.5.5 Southeast Asia Colorectal Cancer Therapeutics Market Size, 2018-2032
6.5.6 India Colorectal Cancer Therapeutics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Colorectal Cancer Therapeutics Revenue, 2018-2032
6.6.2 Brazil Colorectal Cancer Therapeutics Market Size, 2018-2032
6.6.3 Argentina Colorectal Cancer Therapeutics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue, 2018-2032
6.7.2 Turkey Colorectal Cancer Therapeutics Market Size, 2018-2032
6.7.3 Israel Colorectal Cancer Therapeutics Market Size, 2018-2032
6.7.4 Saudi Arabia Colorectal Cancer Therapeutics Market Size, 2018-2032
6.7.5 UAE Colorectal Cancer Therapeutics Market Size, 2018-2032
7 Colorectal Cancer Therapeutics Companies Profiles
7.1 Taiho Pharma
7.1.1 Taiho Pharma Company Summary
7.1.2 Taiho Pharma Business Overview
7.1.3 Taiho Pharma Colorectal Cancer Therapeutics Major Product Offerings
7.1.4 Taiho Pharma Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Taiho Pharma Key News & Latest Developments
7.2 Merck KGaA
7.2.1 Merck KGaA Company Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Colorectal Cancer Therapeutics Major Product Offerings
7.2.4 Merck KGaA Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Merck KGaA Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Colorectal Cancer Therapeutics Major Product Offerings
7.3.4 Amgen Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Takeda
7.4.1 Takeda Company Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Colorectal Cancer Therapeutics Major Product Offerings
7.4.4 Takeda Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Takeda Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Colorectal Cancer Therapeutics Major Product Offerings
7.5.4 Roche Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Colorectal Cancer Therapeutics Major Product Offerings
7.6.4 Eli Lilly Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Colorectal Cancer Therapeutics Major Product Offerings
7.7.4 Sanofi Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Regeneron
7.8.1 Regeneron Company Summary
7.8.2 Regeneron Business Overview
7.8.3 Regeneron Colorectal Cancer Therapeutics Major Product Offerings
7.8.4 Regeneron Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Regeneron Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Colorectal Cancer Therapeutics Major Product Offerings
7.9.4 Bayer Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Bayer Key News & Latest Developments
7.10 Onyx
7.10.1 Onyx Company Summary
7.10.2 Onyx Business Overview
7.10.3 Onyx Colorectal Cancer Therapeutics Major Product Offerings
7.10.4 Onyx Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Onyx Key News & Latest Developments
7.11 Bristol-Myers Squib
7.11.1 Bristol-Myers Squib Company Summary
7.11.2 Bristol-Myers Squib Business Overview
7.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Major Product Offerings
7.11.4 Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Bristol-Myers Squib Key News & Latest Developments
7.12 Sumitomo Dainippon Pharma
7.12.1 Sumitomo Dainippon Pharma Company Summary
7.12.2 Sumitomo Dainippon Pharma Business Overview
7.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Major Product Offerings
7.12.4 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.13 Array BioPharma
7.13.1 Array BioPharma Company Summary
7.13.2 Array BioPharma Business Overview
7.13.3 Array BioPharma Colorectal Cancer Therapeutics Major Product Offerings
7.13.4 Array BioPharma Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Array BioPharma Key News & Latest Developments
7.14 Hutchison MediPharma
7.14.1 Hutchison MediPharma Company Summary
7.14.2 Hutchison MediPharma Business Overview
7.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Major Product Offerings
7.14.4 Hutchison MediPharma Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.14.5 Hutchison MediPharma Key News & Latest Developments
7.15 Jiangsu Hengrui Medicine
7.15.1 Jiangsu Hengrui Medicine Company Summary
7.15.2 Jiangsu Hengrui Medicine Business Overview
7.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Major Product Offerings
7.15.4 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.15.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.16 Jiangsu Chia-Tai Tianqing
7.16.1 Jiangsu Chia-Tai Tianqing Company Summary
7.16.2 Jiangsu Chia-Tai Tianqing Business Overview
7.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Major Product Offerings
7.16.4 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Jiangsu Chia-Tai Tianqing Key News & Latest Developments
7.17 Suzhou Zelgen Biopharmaceuticals
7.17.1 Suzhou Zelgen Biopharmaceuticals Company Summary
7.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview
7.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Major Product Offerings
7.17.4 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue in Global Market (2018-2023)
7.17.5 Suzhou Zelgen Biopharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Colorectal Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Colorectal Cancer Therapeutics Market Drivers in Global Market
Table 3. Colorectal Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Colorectal Cancer Therapeutics in Global Market
Table 5. Top Colorectal Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Colorectal Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Colorectal Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Colorectal Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Colorectal Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colorectal Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Colorectal Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Colorectal Cancer Therapeutics Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2024-2032
Table 30. Taiho Pharma Company Summary
Table 31. Taiho Pharma Colorectal Cancer Therapeutics Product Offerings
Table 32. Taiho Pharma Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Taiho Pharma Key News & Latest Developments
Table 34. Merck KGaA Company Summary
Table 35. Merck KGaA Colorectal Cancer Therapeutics Product Offerings
Table 36. Merck KGaA Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Merck KGaA Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen Colorectal Cancer Therapeutics Product Offerings
Table 40. Amgen Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Takeda Company Summary
Table 43. Takeda Colorectal Cancer Therapeutics Product Offerings
Table 44. Takeda Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Colorectal Cancer Therapeutics Product Offerings
Table 48. Roche Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Colorectal Cancer Therapeutics Product Offerings
Table 52. Eli Lilly Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Colorectal Cancer Therapeutics Product Offerings
Table 56. Sanofi Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Regeneron Company Summary
Table 59. Regeneron Colorectal Cancer Therapeutics Product Offerings
Table 60. Regeneron Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Regeneron Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Colorectal Cancer Therapeutics Product Offerings
Table 64. Bayer Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Onyx Company Summary
Table 67. Onyx Colorectal Cancer Therapeutics Product Offerings
Table 68. Onyx Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Onyx Key News & Latest Developments
Table 70. Bristol-Myers Squib Company Summary
Table 71. Bristol-Myers Squib Colorectal Cancer Therapeutics Product Offerings
Table 72. Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Bristol-Myers Squib Key News & Latest Developments
Table 74. Sumitomo Dainippon Pharma Company Summary
Table 75. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product Offerings
Table 76. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Sumitomo Dainippon Pharma Key News & Latest Developments
Table 78. Array BioPharma Company Summary
Table 79. Array BioPharma Colorectal Cancer Therapeutics Product Offerings
Table 80. Array BioPharma Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. Array BioPharma Key News & Latest Developments
Table 82. Hutchison MediPharma Company Summary
Table 83. Hutchison MediPharma Colorectal Cancer Therapeutics Product Offerings
Table 84. Hutchison MediPharma Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. Hutchison MediPharma Key News & Latest Developments
Table 86. Jiangsu Hengrui Medicine Company Summary
Table 87. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product Offerings
Table 88. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 89. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 90. Jiangsu Chia-Tai Tianqing Company Summary
Table 91. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product Offerings
Table 92. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 93. Jiangsu Chia-Tai Tianqing Key News & Latest Developments
Table 94. Suzhou Zelgen Biopharmaceuticals Company Summary
Table 95. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product Offerings
Table 96. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 97. Suzhou Zelgen Biopharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Colorectal Cancer Therapeutics Segment by Type in 2022
Figure 2. Colorectal Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Colorectal Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Colorectal Cancer Therapeutics Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Colorectal Cancer Therapeutics Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colorectal Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 9. By Application - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 10. By Type - Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 12. By Application - Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 14. By Region - Global Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 15. By Country - North America Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 16. US Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 20. Germany Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 21. France Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 28. China Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 32. India Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 34. Brazil Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue Market Share, 2018-2032
Figure 37. Turkey Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 41. Taiho Pharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck KGaA Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Regeneron Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bayer Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Onyx Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Array BioPharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Hutchison MediPharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
